We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.31B
AUM Growth
-$238M
Cap. Flow
-$311M
Cap. Flow %
-23.85%
Top 10 Hldgs %
52.69%
Holding
138
New
20
Increased
29
Reduced
47
Closed
14

Top Buys

Rank Stock Value
1
QURE icon
uniQure
QURE
+$7.76M
2
CVT
Cvent Holding Corp. Common Stock
CVT
+$6.1M
3
APEN
Apollo Endosurgery, Inc.
APEN
+$5.13M
4
ILPT
Industrial Logistics Properties Trust
ILPT
+$4.93M
5
IMAX icon
IMAX
IMAX
+$4.42M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$92.1M
2
TA
TravelCenters of America LLC
TA
+$28.5M
3
PAYA
Paya Holdings Inc. Class A Common Stock
PAYA
+$19.4M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$10.1M
5
ALTG icon
Alta Equipment Group
ALTG
+$9.43M

Sector Composition

Rank Sector Weight
1 Healthcare 38.41%
2 Consumer Discretionary 14.33%
3 Communication Services 6.54%
4 Financials 5.4%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
76
Disc Medicine
IRON
$3.12B
$1.9M 0.15%
89,538
-73,224
-45% -$1.63M
RILY icon
77
BRC Group Holdings
RILY
$292M
$1.77M 0.14%
62,520
-5,776
-8% -$219K
DAKT icon
78
Daktronics
DAKT
$1.02B
$1.66M 0.13%
292,187
– –
ADCT icon
79
ADC Therapeutics
ADCT
$150M
$1.64M 0.13%
840,000
+596,710
+245% +$2.2M
SLNO
80
DELISTED
Soleno Therapeutics
SLNO
$1.5M 0.11%
699,364
+95,185
+16% +$214K
ANEB
81
DELISTED
Anebulo Pharmaceuticals
ANEB
$1.48M 0.11%
511,073
– –
RZLT icon
82
Rezolute
RZLT
$445M
$1.48M 0.11%
769,606
+50,870
+7% +$115K
CVNA icon
83
CALL
Carvana
CVNA
$79.2B
$1.47M 0.11%
750,000
– –
IMTXW
84
DELISTED
Immatics N.V. Warrants
IMTXW
$1.42M 0.11%
986,101
– –
AVTX icon
85
Avalo Therapeutics
AVTX
$1.04B
$1.42M 0.11%
3,370
+1,117
+50% +$880K
EHTH icon
86
CALL
eHealth
EHTH
$39.1M
$1.39M 0.11%
+148,600
New +$1.17M
RNAC icon
87
Cartesian Therapeutics
RNAC
$260M
$1.39M 0.11%
+33,333
New +$1.57M
UNCY icon
88
Unicycive Therapeutics
UNCY
$137M
$1.36M 0.1%
64,742
– –
TSHA icon
89
Taysha Gene Therapies
TSHA
$1.92B
$1.35M 0.1%
1,722,400
-1,277,365
-43% -$1.65M
SYRE icon
90
Spyre Therapeutics
SYRE
$9.06B
$1.32M 0.1%
182,320
-2,132
-1% -$23.4K
AKU
91
DELISTED
Akumin Inc
AKU
$1.28M 0.1%
1,886,856
-320,104
-15% -$315K
WNC icon
92
PUT
Wabash National
WNC
$505M
$1.23M 0.09%
50,000
-16,700
-25% -$433K
GPCR icon
93
Structure Therapeutics
GPCR
$3.71B
$1.19M 0.09%
+50,000
New +$1.17M
CYTK icon
94
Cytokinetics
CYTK
$10.6B
$1.06M 0.08%
30,000
+25,198
+525% +$1.03M
SRTS icon
95
Sensus Healthcare
SRTS
$51M
$964K 0.07%
+185,048
New +$1.33M
ACER
96
DELISTED
Acer Therapeutics Inc
ACER
$913K 0.07%
1,203,126
-23,065
-2% -$45.5K
SCYX icon
97
SCYNEXIS
SCYX
$48M
$900K 0.07%
+37,500
New +$498K
SGRP
98
DELISTED
SPAR Group
SGRP
$899K 0.07%
696,578
+158,151
+29% +$205K
LFCR icon
99
Lifecore Biomedical
LFCR
$183M
$735K 0.06%
+194,700
New +$1.09M
AMRX icon
100
Amneal Pharmaceuticals
AMRX
$5.46B
$695K 0.05%
+500,000
New +$996K
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return

Nantahala Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Nantahala Capital Management held 138 positions worth $1.31B, down 15% from $1.54B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Nantahala Capital Management withdrew a net $311M in Q1 2023, closing 14 positions and reducing 47 holdings. Its most notable exit was Paya Holdings Inc. Class A Common Stock, an estimated $19.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Nantahala Capital Management opened a new position in Cvent Holding Corp. Common Stock worth $7.06M.

  • Nantahala Capital Management's largest Q1 2023 buy was Cvent Holding Corp. Common Stock: 845,000 shares worth $7.06M.
  • Nantahala Capital Management added most to uniQure in Q1 2023, an estimated $7.76M increase.
  • Nantahala Capital Management's biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $92.1M.
  • Nantahala Capital Management fully exited Paya Holdings Inc. Class A Common Stock in Q1 2023, selling an estimated $19.4M.
  • Nantahala Capital Management's ten largest holdings make up 53% of its $1.31B portfolio in Q1 2023.
  • Nantahala Capital Management opened 20 new positions and closed 14 in Q1 2023.
  • Nantahala Capital Management's portfolio value fell 15% quarter-over-quarter to $1.31B.

Based on Nantahala Capital Management's 13F filing for Q1 2023, filed 15 May 2023.